Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXL with Hypo-osmolar Riboflavin in Thin Corneas
NCT01485211Phase 4Completed
- Sponsor
- Instituto de Olhos de Goiânia
- Start
- Jan 2010
- Primary completion
- Nov 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of riboflavin in keratoconus, sponsored by Instituto de Olhos de Goiânia. Started Jan 2010; status: completed.
02
Drugs
riboflavin
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT01485211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01485211.